# Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy

> **NCT04430088** · PHASE3 · UNKNOWN · sponsor: **Vivozon, Inc.** · enrollment: 300 (estimated)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** VVZ-149 Injections
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04430088
- **Lead sponsor:** Vivozon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-26
- **Primary completion:** 2020-12
- **Final completion:** 2021-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04430088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04430088, "Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04430088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*